Background: The presence of an inflammatory infiltrate consisting of helper T cells and a dysregulated matrix metabolism leading to excessive deposition of collagen are two pathogenetic factors ...

A retrospective cohort study found no significant associations between phototherapy without psoralens and the risk of skin cancer. Patients undergoing phototherapy without psoralens are not at an ...

Please provide your email address to receive an email when new articles are posted on . Ultraviolet B phototherapy was not linked to an increased risk of skin cancer (adjusted HR = 0.91). The number ...

Intervale, New Hampshire--(Newsfile Corp. - June 26, 2025) - Cytokind, a medical device and drug discovery company, is featured in the June 2025 issue of Scientific American in Rowan Jacobsen's ...

Please provide your email address to receive an email when new articles are posted on . What psoriasis treatment is as effective as adalimumab but achieves better overall improvement in health-related ...

Add Yahoo as a preferred source to see more of our stories on Google. Can exposure to the sun or other specific types of light help those dealing with chronic psoriasis? We took a look at the science ...

INTERVALE, N.H., Oct. 28, 2025 /PRNewswire/ -- Cytokind announces recently published results in the peer-reviewed Multiple Sclerosis and Related Disorders journal, demonstrating that narrowband UVB ...

Baricitinib, a Janus kinase (JAK) inhibitor, combined with narrowband ultraviolet B (UVB) phototherapy, reduced disease activity and improved repigmentation and quality of life in adults with ...

Adding twice-weekly narrowband UVB phototherapy to oral ritlecitinib may enhance response to treatment of nonsegmental vitiligo. Dual treatment was well-tolerated with no new safety signals in this ...

MIAMI BEACH -- Narrowband UVB therapy may be a better treatment for vitamin D deficiency than supplementation, Swedish researchers reported here. In a small, single-center study, patients deficient in ...

STEPIn enrolled systemic- and phototherapy-naïve adults with plaque psoriasis ≤1 year and randomized secukinumab 300 mg versus nb-UVB for 52 weeks, then observed off-treatment to week 104. Off-therapy ...